Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

GEMFIBROZIL vs JUXTAPID

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. GEMFIBROZIL and JUXTAPID are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

gemfibroziljuxtapid

Rating

70/100
70/100

Pharmacy pays

~$3.09 /30
—

Type

RX
RX

Active ingredient

GEMFIBROZIL
LOMITAPIDE MESYLATE

Manufacturer

Cadila Pharms Ltd
Chiesi

Dosage forms

Tablet
Capsule

Drug class

Peroxisome Proliferator Receptor Alpha Agonist
—

Boxed warning

None
Boxed warning

Treats

Coronary Artery Disease, Hypercholesterolemia, Hyperlipoproteinemias
Hypercholesterolemia

Frequently asked questions

Which is better-rated, Gemfibrozil or Juxtapid?

Gemfibrozil and Juxtapid are tied at 3.5 out of 5 by our independent rating.

What is the difference between Gemfibrozil and Juxtapid?

Gemfibrozil contains Gemfibrozil, while Juxtapid contains Lomitapide Mesylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.